$10,000 of ELI LILLY & COMPANY lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Monitored Issues and advised clients on matters related to Pharmaceutical supply chain security and resiliency."
You can find more data on corporate lobbying on Quiver Quantitative.
LLY Congressional Stock Trading
Members of Congress have traded $LLY stock 22 times in the past 6 months. Of those trades, 10 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $LLY stock by members of Congress over the last 6 months:
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/22, 08/11 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 08/14.
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 2 purchases worth up to $65,000 on 08/14 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 07/10 and 2 sales worth up to $30,000 on 07/16, 06/09.
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 4 times. They made 2 purchases worth up to $65,000 on 04/23, 04/21 and 2 sales worth up to $65,000 on 06/03, 05/21.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/30.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/14, 05/05 and 0 sales.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/01 and 1 sale worth up to $15,000 on 05/13.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 05/06.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LLY Insider Trading Activity
LLY insiders have traded $LLY stock on the open market 119 times in the past 6 months. Of those trades, 9 have been purchases and 110 have been sales.
Here’s a breakdown of recent trading of $LLY stock by insiders over the last 6 months:
- ENDOWMENT INC LILLY has made 0 purchases and 106 sales selling 1,255,382 shares for an estimated $1,017,441,058.
- ILYA YUFFA (EVP&Pres, LLY USA&Global Capab) has made 0 purchases and 2 sales selling 2,500 shares for an estimated $1,720,312.
- DONALD A ZAKROWSKI (SVP, Finance, & CAO) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $1,451,340.
- DAVID A RICKS (President, Chair, and CEO) purchased 1,632 shares for an estimated $1,052,263
- J ERIK FYRWALD has made 2 purchases buying 1,565 shares for an estimated $1,005,242 and 0 sales.
- NAARDEN JACOB VAN (EVP & Pres., Lilly Oncology) purchased 1,000 shares for an estimated $647,360
- DANIEL SKOVRONSKY (EVP, CSO & Pres. LRL & LLY Imm) purchased 1,000 shares for an estimated $634,405
- RALPH ALVAREZ purchased 758 shares for an estimated $500,472
- LUCAS MONTARCE (EVP & CFO) purchased 715 shares for an estimated $494,626
- JAMERE JACKSON purchased 200 shares for an estimated $127,912
- GABRIELLE SULZBERGER purchased 117 shares for an estimated $75,018
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LLY Hedge Fund Activity
We have seen 1,905 institutional investors add shares of LLY stock to their portfolio, and 1,609 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PNC FINANCIAL SERVICES GROUP, INC. removed 50,011,670 shares (-49.4%) from their portfolio in Q2 2025, for an estimated $38,985,597,115
- CAPITAL RESEARCH GLOBAL INVESTORS added 5,008,900 shares (+31.8%) to their portfolio in Q2 2025, for an estimated $3,904,587,817
- FMR LLC removed 2,838,895 shares (-10.0%) from their portfolio in Q2 2025, for an estimated $2,213,003,819
- PRIMECAP MANAGEMENT CO/CA/ removed 2,624,862 shares (-17.8%) from their portfolio in Q2 2025, for an estimated $2,046,158,674
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,288,179 shares (-12.0%) from their portfolio in Q2 2025, for an estimated $1,783,704,175
- GQG PARTNERS LLC removed 1,556,859 shares (-85.1%) from their portfolio in Q2 2025, for an estimated $1,213,618,296
- AMUNDI removed 1,391,901 shares (-28.1%) from their portfolio in Q2 2025, for an estimated $1,085,028,586
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LLY Analyst Ratings
Wall Street analysts have issued reports on $LLY in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 10/08/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/13/2025
- Deutsche Bank issued a "Buy" rating on 08/11/2025
- UBS issued a "Buy" rating on 08/08/2025
- HSBC issued a "Reduce" rating on 04/28/2025
To track analyst ratings and price targets for LLY, check out Quiver Quantitative's $LLY forecast page.
LLY Price Targets
Multiple analysts have issued price targets for $LLY recently. We have seen 8 analysts offer price targets for $LLY in the last 6 months, with a median target of $897.5.
Here are some recent targets:
- Seamus Fernandez from Guggenheim set a target price of $948.0 on 10/08/2025
- Terence Flynn from Morgan Stanley set a target price of $1023.0 on 10/03/2025
- Kerry Holford from Berenberg set a target price of $830.0 on 09/17/2025
- Chris Schott from JP Morgan set a target price of $1050.0 on 09/16/2025
- Rajesh Kumar from HSBC set a target price of $700.0 on 08/27/2025
- Carter Gould from Cantor Fitzgerald set a target price of $825.0 on 08/13/2025
- James Shin from Deutsche Bank set a target price of $900.0 on 08/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
